FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

386900007: Palivizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461078016 Palivizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481014019 Palivizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Palivizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Palivizumab Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Palivizumab Is a Substance with antiviral mechanism of action true Inferred relationship Existential restriction modifier
Palivizumab Has disposition Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Palivizumab Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Palivizumab Has disposition Antiviral true Inferred relationship Existential restriction modifier
Palivizumab Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing palivizumab Has active ingredient True Palivizumab Inferred relationship Existential restriction modifier 1
Palivizumab 50mg powder and solvent for injection solution vial Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg injection Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg powder for injection 1mL vial Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg powder and solvent for injection solution vial Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection Has precise active ingredient True Palivizumab Inferred relationship Existential restriction modifier 1
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection Has basis of strength substance True Palivizumab Inferred relationship Existential restriction modifier 1
Product containing precisely palivizumab 50 milligram/1 vial powder for conventional release solution for injection Has precise active ingredient True Palivizumab Inferred relationship Existential restriction modifier 1
Product containing precisely palivizumab 50 milligram/1 vial powder for conventional release solution for injection Has basis of strength substance True Palivizumab Inferred relationship Existential restriction modifier 1
Product containing palivizumab in parenteral dose form (medicinal product form) Has active ingredient True Palivizumab Inferred relationship Existential restriction modifier 1
Palivizumab Has active ingredient True Palivizumab Inferred relationship Existential restriction modifier 1
Product containing only palivizumab in parenteral dose form (medicinal product form) Has active ingredient True Palivizumab Inferred relationship Existential restriction modifier 1
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Palivizumab Inferred relationship Existential restriction modifier 1
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Palivizumab Inferred relationship Existential restriction modifier 1
Palivizumab 100mg injection (pdr for recon)+solvent - product Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg injection (pdr for recon)+solvent - product Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Synagis 50mg injection (pdr for recon)+solvent Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Synagis 100mg injection (pdr for recon)+solvent Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Synagis 100mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) Has active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Synagis 50mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) Has active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg powder and solvent for solution for injection vials 1 vial Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Synagis 100mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) 1 vial Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Synagis 50mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) 1 vial Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Synagis 100mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg powder and solvent for injection solution vial Has specific active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Synagis 100mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) 1 vial Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Synagis 50mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for injection solution vial Has specific active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Synagis 50mg powder and solvent for solution for injection vials (Abbott Laboratories Ltd) 1 vial Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg/1ml solution for injection vials Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg/1ml solution for injection vials Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Has active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Synagis 100mg/1ml solution for injection vials (AstraZeneca UK Ltd) Has active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Synagis 100mg/1ml solution for injection vials (AstraZeneca UK Ltd) Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg/1ml solution for injection vials 1 vial Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials 1 vial Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Synagis 50mg/0.5ml solution for injection vials (AstraZeneca UK Ltd) 1 vial Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Synagis 100mg/1ml solution for injection vials (AstraZeneca UK Ltd) 1 vial Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg powder and solvent for solution for injection vials Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials Has specific active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg powder and solvent for solution for injection vials Has specific active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg powder and solvent for solution for injection vials Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 100mg powder and solvent for solution for injection vials Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials Has active ingredient False Palivizumab Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials Has specific active ingredient True Palivizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start